
    
      Planned enrollment includes 3 subjects at each dose level. TG-1501 will be administered as a
      60-minute IV infusion at fixed dose levels on Days 1 and 15 of every 28-day cycle or only on
      Day 1 of every 28-day cycle.
    
  